EMA revises the guideline for environmental risk assessment of medicinal products for human use
By Sharon Robinson and Kadi Kuuskmae-Perry2024-08-13T10:00:00
The legislative requirement for the conduct of environmental risk assessments (ERAs) in the EU is not new, with the original guidance having been issued 18 years ago. However, 1 September 2024 marks the day when the revised guidance on the conduct of ERAs becomes effective, having been in the making since 2016 when the concept paper on the revision of the original ERA guidance was first released. This article discusses and analyses key changes of this revised guidance.